SMTL ID : 9bfz.2 (1 other biounit)

Tri-complex of Compound-5, KRAS G12C, and CypA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)

GNP.1: 24 residues within 4Å: Chain A: A.12, C.13, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, Y.33, P.35, T.36, A.60, G.61, N.117, K.118, D.120, L.121, S.146, A.147, K.148 Ligands: MG.2 24 PLIP interactions: 24 interactions with chain A Hydrogen bonds: A:G.14, A:V.15, A:G.16, A:K.17, A:K.17, A:S.18, A:A.19, A:V.30, A:T.36, A:T.36, A:G.61, A:N.117, A:K.118, A:K.118, A:A.147, A:K.148 Water bridges: A:S.18, A:S.18, A:D.31, A:D.34, A:T.36 Salt bridges: A:D.120 pi-Stacking: A:F.29, A:F.29

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: S.18, T.36 Ligands: GNP.1 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:S.18, A:T.36, H2O.1, H2O.1

1 x 01: (3R)-N-[(2S)-1-{[(1M,8R,10S,14S,21M)-22-ethyl-4-hydroxy-21-[2-(2-methoxyethyl)phenyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.1~2,6~.1~10,14~.0~23,27~]nonacosa-1(25),2(29),3,5,20,23,26-heptaen-8-yl]amino}-3-methyl-1-oxobutan-2-yl]-N-methyl-1-propanoylpyrrolidine-3-carboxamide (non-preferred name)

01.3: 27 residues within 4Å: Chain A: C.13, Y.33, P.35, T.36, I.37, E.38, A.60, G.61, Q.62, Y.65, M.68, Y.72 Chain B: R.56, I.58, F.61, M.62, Q.64, G.73, T.74, A.102, N.103, A.104, Q.112, F.114, L.123, H.127, R.149 25 PLIP interactions: 8 interactions with chain A, 17 interactions with chain B Hydrophobic interactions: A:Y.33, A:I.37, A:A.60, A:Y.65, A:M.68, B:I.58, B:F.61, B:F.61, B:A.102, B:Q.112, B:F.114, B:L.123 Water bridges: A:Y.33, A:T.36, B:R.149 pi-Stacking: A:Y.65 Hydrogen bonds: B:R.56, B:R.56, B:Q.64, B:Q.64, B:N.103, B:N.103, B:R.149 Salt bridges: B:R.56 pi-Cation interactions: B:R.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cregg, J. et al., Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers. J.Med.Chem. (2025)

Release Date

2025-03-05

Peptides

GTPase KRas: A
Peptidyl-prolyl cis-trans isomerase A: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

GTPase KRas

Peptidyl-prolyl cis-trans isomerase A

Related Entries With Identical Sequence